EyePoint Pharmaceuticals Statistics
Total Valuation
EYPT has a market cap or net worth of $347.08 million. The enterprise value is -$1.42 million.
Important Dates
The last earnings date was Wednesday, March 5, 2025, before market open.
| Earnings Date | Mar 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EYPT has 68.73 million shares outstanding. The number of shares has increased by 44.71% in one year.
| Current Share Class | 68.73M |
| Shares Outstanding | 68.73M |
| Shares Change (YoY) | +44.71% |
| Shares Change (QoQ) | +18.56% |
| Owned by Insiders (%) | 0.95% |
| Owned by Institutions (%) | 72.83% |
| Float | 43.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.05 |
| Forward PS | 16.02 |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.03 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.81, with a Debt / Equity ratio of 0.07.
| Current Ratio | 7.81 |
| Quick Ratio | 7.57 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10,418.14 |
Financial Efficiency
Return on equity (ROE) is -43.42% and return on invested capital (ROIC) is -28.88%.
| Return on Equity (ROE) | -43.42% |
| Return on Assets (ROA) | -23.57% |
| Return on Invested Capital (ROIC) | -28.88% |
| Return on Capital Employed (ROCE) | -39.48% |
| Revenue Per Employee | $262,261 |
| Profits Per Employee | -$793,152 |
| Employee Count | 165 |
| Asset Turnover | 0.11 |
| Inventory Turnover | 7.14 |
Taxes
In the past 12 months, EYPT has paid $90,000 in taxes.
| Income Tax | 90,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.94% in the last 52 weeks. The beta is 1.42, so EYPT's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -74.94% |
| 50-Day Moving Average | 6.72 |
| 200-Day Moving Average | 8.39 |
| Relative Strength Index (RSI) | 29.92 |
| Average Volume (20 Days) | 726,538 |
Short Selling Information
The latest short interest is 10.83 million, so 15.76% of the outstanding shares have been sold short.
| Short Interest | 10.83M |
| Short Previous Month | 10.73M |
| Short % of Shares Out | 15.76% |
| Short % of Float | 24.87% |
| Short Ratio (days to cover) | 13.37 |
Income Statement
In the last 12 months, EYPT had revenue of $43.27 million and -$130.87 million in losses. Loss per share was -$2.32.
| Revenue | 43.27M |
| Gross Profit | 21.09M |
| Operating Income | -145.85M |
| Pretax Income | -86.74M |
| Net Income | -130.87M |
| EBITDA | -144.31M |
| EBIT | -145.85M |
| Loss Per Share | -$2.32 |
Full Income StatementBalance Sheet
The company has $370.91 million in cash and $23.11 million in debt, giving a net cash position of $347.81 million or $5.06 per share.
| Cash & Cash Equivalents | 370.91M |
| Total Debt | 23.11M |
| Net Cash | 347.81M |
| Net Cash Per Share | $5.06 |
| Equity (Book Value) | 336.50M |
| Book Value Per Share | 4.93 |
| Working Capital | 334.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$126.23 million and capital expenditures -$4.05 million, giving a free cash flow of -$130.28 million.
| Operating Cash Flow | -126.23M |
| Capital Expenditures | -4.05M |
| Free Cash Flow | -130.28M |
| FCF Per Share | -$1.90 |
Full Cash Flow StatementMargins
| Gross Margin | 48.73% |
| Operating Margin | -337.06% |
| Pretax Margin | -302.22% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EYPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -44.71% |
| Shareholder Yield | -44.71% |
| Earnings Yield | -37.78% |
| FCF Yield | -37.61% |
Analyst Forecast
The average price target for EYPT is $25.71, which is 409.11% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $25.71 |
| Price Target Difference | 409.11% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 66.30% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 9, 2020. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Dec 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
EYPT has an Altman Z-Score of 2.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.36 |
| Piotroski F-Score | 2 |